If you’re one of the 35 million people living with a chronic lung disease in the United States, the form of treatment you ...
After assessing data from the first 46 adults with refractory nontuberculous mycobacterial lung disease who completed the ...
A phase 3 trial evaluating a nebulized clofazimine inhalation suspension (MNKD-101) for the treatment of refractory nontuberculous mycobacterial (NTM) ...
The latest announcement is out from BiomX ( (PHGE) ).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback